DK0443891T3 - Anvendelse af N-myristotyl-(S)-phenylalanin eller et additionssalt deraf med en farmaceutisk acceptabel base til opnåelse af et farmaceutisk middel og farmaceutisk middel til behandling af sygdomme ved indgribning i myristoyleringen - Google Patents

Anvendelse af N-myristotyl-(S)-phenylalanin eller et additionssalt deraf med en farmaceutisk acceptabel base til opnåelse af et farmaceutisk middel og farmaceutisk middel til behandling af sygdomme ved indgribning i myristoyleringen

Info

Publication number
DK0443891T3
DK0443891T3 DK91400163.1T DK91400163T DK0443891T3 DK 0443891 T3 DK0443891 T3 DK 0443891T3 DK 91400163 T DK91400163 T DK 91400163T DK 0443891 T3 DK0443891 T3 DK 0443891T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical
phenylalanine
diseases
treatment
myristotyl
Prior art date
Application number
DK91400163.1T
Other languages
Danish (da)
English (en)
Inventor
Michel Vincent
Georges Remond
Yolande Herve
Jean-Albert Boutin
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of DK0443891T3 publication Critical patent/DK0443891T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/005—Enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK91400163.1T 1990-01-25 1991-01-25 Anvendelse af N-myristotyl-(S)-phenylalanin eller et additionssalt deraf med en farmaceutisk acceptabel base til opnåelse af et farmaceutisk middel og farmaceutisk middel til behandling af sygdomme ved indgribning i myristoyleringen DK0443891T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9000834A FR2657259A1 (fr) 1990-01-25 1990-01-25 Utilisation de la n-myristoyl-(s)-phenylalanine pour l'obtention de medicaments destines au traitement des maladies faisant intervenir la myristoylation.

Publications (1)

Publication Number Publication Date
DK0443891T3 true DK0443891T3 (da) 1993-12-27

Family

ID=9393082

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91400163.1T DK0443891T3 (da) 1990-01-25 1991-01-25 Anvendelse af N-myristotyl-(S)-phenylalanin eller et additionssalt deraf med en farmaceutisk acceptabel base til opnåelse af et farmaceutisk middel og farmaceutisk middel til behandling af sygdomme ved indgribning i myristoyleringen

Country Status (14)

Country Link
US (1) US5164414A (pt)
EP (1) EP0443891B1 (pt)
JP (1) JPH0717503B2 (pt)
AT (1) ATE94387T1 (pt)
AU (1) AU633395B2 (pt)
CA (1) CA2034861A1 (pt)
DE (1) DE69100364T2 (pt)
DK (1) DK0443891T3 (pt)
ES (1) ES2060310T3 (pt)
FR (1) FR2657259A1 (pt)
IE (1) IE65573B1 (pt)
OA (1) OA09478A (pt)
PT (1) PT96571A (pt)
ZA (1) ZA91574B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672598A1 (fr) * 1991-02-11 1992-08-14 Adir Nouveaux inhibiteurs de n-myristoyltransferase, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
US6127393A (en) * 1995-12-29 2000-10-03 Novactyl, Inc. Antiproliferative, antiinfective, antiinflammatory, autologous immunization agent and method
US6407125B1 (en) 1995-12-29 2002-06-18 Novactyl, Inc. Pharmacological agent and method of treatment
US6743771B2 (en) 1995-12-29 2004-06-01 Novactyl, Inc. Methods and compositions for controlling protein assembly or aggregation
US6579891B1 (en) 1995-12-29 2003-06-17 Novactyl, Inc. Agent and method for prevention and treatment of cancer in animals
US6441009B1 (en) 1998-08-01 2002-08-27 Novactyl, Inc. Agent and method of preventing and treating heavy metal exposure and toxicity
WO2001037827A1 (en) * 1999-10-13 2001-05-31 Chacon Marco A Therapeutic intervention to mimic the effect of caloric restriction
US6403618B1 (en) 2000-02-15 2002-06-11 Novactyl, Inc. Agent and method for controlling angiogenesis
WO2003007876A2 (en) * 2001-06-25 2003-01-30 University Of Massachusetts N-fatty acid-amino acid conjugates and therapeutic uses
DE10353806A1 (de) * 2003-11-14 2005-07-07 Bundesrepublik Deutschland, vertreten durch das Bundesministerium für Gesundheit, dieses vertreten durch das Robert-Koch-Institut, vertreten durch seinen Präsidenten Verwendung von Aminosäure- und Zucker-Amphiphilen zur Inaktivierung von lipidumhüllten Viren
US7544714B2 (en) * 2004-07-16 2009-06-09 University Of Massachusetts Lipid-amino acid conjugates and methods of use
IL172896A0 (en) * 2005-12-29 2006-06-11 Yeda Res & Dev Cxcr4 inhibition
WO2013013302A1 (en) * 2011-07-22 2013-01-31 Pacylex Pharmaceuticals Inc. Synthetic lethality and the treatment of cancer
BR112014023016B1 (pt) 2012-03-30 2020-10-27 Givaudan Sa composição de sabor e composição comestível
KR102045590B1 (ko) 2012-03-30 2019-11-15 지보당 에스아 식품 향미 화합물로서의 n-아실화된 1-아미노사이클로알킬 카복실산
WO2013149019A1 (en) 2012-03-30 2013-10-03 Givaudan S.A. N-acylated methionine derivatives as food flavouring compounds
SG11201405413SA (en) 2012-03-30 2014-10-30 Givaudan Sa N-acyl derivatives of gamma amino - butyric acid and and beta alanine as food flavouring compounds
SG11201405295WA (en) 2012-03-30 2014-11-27 Givaudan Sa N-acyl-amino acid derivatives for improvement of the flavour profile edible|compositions
EP2830438B1 (en) 2012-03-30 2019-09-04 Givaudan SA N-acyl derivatives of gamma amino-butyric acid as food flavouring compounds, powder compositions containing them
SG11201405342TA (en) 2012-03-30 2014-10-30 Givaudan Sa N-acyl proline derivatives as food flavouring compounds
ES2856701T3 (es) * 2012-10-30 2021-09-28 Pacylex Pharmaceuticals Inc Letalidad sintética y tratamiento del cáncer
WO2015050536A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. N-acylated 2-aminoisobutyric acid compounds and flavour compositions containing them
EP3057445B1 (en) 2013-10-02 2018-07-04 Givaudan SA Organic compounds having taste-modifying properties
WO2015050538A1 (en) * 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
US10537127B2 (en) 2013-10-02 2020-01-21 Givaudan S.A. Organic compounds
EP3057444B1 (en) 2013-10-02 2017-12-06 Givaudan SA Organic compounds having taste-modifying properties
WO2015050535A1 (en) 2013-10-02 2015-04-09 Givaudan S.A. Organic compounds
EP3057448B1 (en) 2013-10-02 2017-12-06 Givaudan S.A. Organic compounds having taste-modifying properties
GB201317424D0 (en) 2013-10-02 2013-11-13 Givaudan Sa Improvements in or relating to organic compounds
EP3325662B1 (en) 2015-07-17 2023-08-30 Pacylex Pharmaceuticals Inc. Epigenetic silencing of nmt2

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4778877A (en) * 1986-08-07 1988-10-18 Washington University Novel inhibitor peptides II
US4778878A (en) * 1986-08-07 1988-10-18 Washington University Novel inhibitor peptides I

Also Published As

Publication number Publication date
IE65573B1 (en) 1995-11-01
AU633395B2 (en) 1993-01-28
ES2060310T3 (es) 1994-11-16
AU6998791A (en) 1991-08-01
JPH0717503B2 (ja) 1995-03-01
JPH04210916A (ja) 1992-08-03
US5164414A (en) 1992-11-17
OA09478A (fr) 1992-11-15
IE910242A1 (en) 1991-07-31
DE69100364D1 (de) 1993-10-21
PT96571A (pt) 1991-10-15
FR2657259A1 (fr) 1991-07-26
ZA91574B (en) 1991-11-27
EP0443891B1 (fr) 1993-09-15
DE69100364T2 (de) 1994-04-21
ATE94387T1 (de) 1993-10-15
FR2657259B1 (pt) 1994-08-19
CA2034861A1 (fr) 1991-07-26
EP0443891A1 (fr) 1991-08-28

Similar Documents

Publication Publication Date Title
DK0443891T3 (da) Anvendelse af N-myristotyl-(S)-phenylalanin eller et additionssalt deraf med en farmaceutisk acceptabel base til opnåelse af et farmaceutisk middel og farmaceutisk middel til behandling af sygdomme ved indgribning i myristoyleringen
NO894296D0 (no) Fremgangsmaate for behandling av leddgikt og betennelsessykdommer.
DE59101397D1 (de) O-glycosyliertes ifn-alpha.
DK156098C (da) Thixotropt middel til brug ved fraktionering af blod
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
ES2071663T3 (es) Analogo de fluoxetina.
NO931413L (no) Fremgangsmaater og preparater for behandling av celleproliferasjonssykdommer
DK160816C (da) Benzoyl-urinstof-derivater, fremgangsmaade til fremstilling af disse, fremgangsmaade til bekaempelse af insektangreb samt insekticidt middel indeholdende disse
IT9020968A0 (it) Metodi e composizioni farmaceutiche per il trattamento di malattie oftalmiche
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK632388A (da) Pharmaceutisk middel til behandling af hyperlipidaemi hol pattedyr
DE69100171D1 (de) Synergistische kombination zur ophthalmischen verwendung.
SE9000948D0 (sv) New use
HU9300388D0 (en) New medical preparatives with 5-(1-hydroxi-2-chlorine-ethyl)-4-methyl-triazole content and method for preparing them
NO960347L (no) Anvendelse av benzydamid ved behandling av patologiske tilstander forårsaket av TNF
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
IT9009354A0 (it) Procedimento e camera di fermentazione per il trattamento di pezzi di pasta alimentare
SE8702227D0 (sv) New use
IT7829846A0 (it) Composizione farmaceutica per la cura della sordita' e del ronzio auricolare.
DK305289A (da) Apparat til behandling af reumatiske sygdomme
NO923078D0 (no) Skumbar sammensetning for farmasoeytisk anvendelse, anvendelse derav og fremgangsmaate for behandling
IT7926323A0 (it) Farmaco per la cura delle leucosi e di sindroni nevrotiche.
ES1009573Y (es) Protesis externa y ajustable para el tratamiento traumatologico de extremidades inferiores.
DK585389D0 (da) Praeparat til behandling af hudsygdomme samt anvendelse af artemisinin og derivater heraf til fremstilling af et saadant praeparat